On the other hand, in glioma cell lines, increasing ECM stiffness causes an increase in BCL9L, a transcriptional coactivator of the β-catenin/TCF complex that favors the gene transcription of its target genes, including PROM1 (gene-coding CD133 protein). This evidence concerns the gene PROM1 and glioma.